Kirsner's inflammatory bowel disease / edited by R. Balfour Sartor, William J. Sandborn
Publication details: Baltimore ; Endinburg : Saunders, c2004, c2000.Edition: 6th editionDescription: xiv, 754 p. : ill. ; 27 cmISBN:- 0721600018
- 978072160001
- WI 420 K611 2004
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Book Open Access
|
Health Sciences Library | WI 420 K611 2004 (Browse shelf(Opens below)) | 1 | Available | MBAL22010721 |
Contents
Section I: Mucosal Protection and homeostasis
1. Intestinal Epithelia barrier function : characteristic and responses to neutrophil transepithelial migration
2. Epithelial restitution and Intestinal repair
3. Epithelial Microbial interactions
4. Immune Cell-Epithelial Cell interactions
5. The regulation of muscol homeostasis and it's relation to inflammatory bowel diseases
6. T-lymphocyte trafficking
7. Leukocyte, platelet and endothelial Cell interactions in the inflammatory bowel disease
Section II: Etiology and Pathogenesis
8. Genetics: Molecular and Chromosomal Consideration
9. Animal Models of Intestinal inflammation
10. microbial influences in inflammatory bowel disease: role in pathogenesis and clinical iplications
11. Mechanisms of tissue injury
12. Cytokines and inflammatory mediators
13. T-lymphocyte dysregulation
14. Neuroimmune interactions in the inflamed intestine
15. Fibrogenesis
16. Colorectal Cancer in Inflammatory bowel disease: molecular considerations
Section III: Epidemiology, Clinical features and natural history
17.The Epidemiology of Inflammatory Bowel Diseases
18. Clinical Genetics of Inflammatory Bowel Diseases
19. Clinical Course and natural history of Ulcerative colitis
20. Clinical features and natural history of Crohn's diseases
21. Clinical features and natural history of pediatric inflammatory bowel diseases
22. Physiologic consequences of surgical treatment for inflammatory bowel disease
23. Fertility and pregnancy
24. Phychosocial factors in ulcerative colitis and crohn's disease
Section IV. Diagnosis and Evaluation
25. Differential Diagnosis of inflammatory bowel disease
26. Endoscopy in Inflammatory Bowel Disease
27. Pathology of Idiopathic Inflammatory Bowel Disease
28. Imaging of the Idiopathic inflammatory bowel disease
29. Serology and laboratory markers of disease activities
Section V. Medical Therapy
30. Clinical trial design with an emphasis on indices to measure disease activity
31. Quality of life and phamacoeconomics
32. Pharmacology of inflammatory bowel disease therapy
33. Medical therapy for ulcerative colitis
34. Medical therapy for crohn's disease
35. Medical and nutritional therapy for pediatric inflammatory bowel disease
36. Nutrition in Inflammatory bowel disease
37. New therapeutic drugs for inflammatory bowel disease
Section VI. Surgical therapy
38. Indications for Surgery in inflammatory bowel disease from the gastroenterologist's point of view
39. Indications for surgery: a surgeon's opinion
40. Surgical management of ulcerative colitis
41. Surgery for Crohn's disease
42. Care of the patient with a fecal diversion
Section VII. Complications and associated diseases
43. Cancer in inflammatory bowel disease-clinical considerations
44. Primary sclerosing cholangitis
45. Extraintestinal manifestation: Skin, joint and mucocutaneous manifestations
46. Pouchitis
47. Postoperative recurrence of crohn's disease
48. Microscopic colitis
49. Fistulizing Crohn's disease
50. Osteoporosis
Includes bibliographies and index.
Contents
Section I: Mucosal Protection and homeostasis
1. Intestinal Epithelia barrier function : characteristic and responses to neutrophil transepithelial migration
2. Epithelial restitution and Intestinal repair
3. Epithelial Microbial interactions
4. Immune Cell-Epithelial Cell interactions
5. The regulation of muscol homeostasis and it's relation to inflammatory bowel diseases
6. T-lymphocyte trafficking
7. Leukocyte, platelet and endothelial Cell interactions in the inflammatory bowel disease
Section II: Etiology and Pathogenesis
8. Genetics: Molecular and Chromosomal Consideration
9. Animal Models of Intestinal inflammation
10. microbial influences in inflammatory bowel disease: role in pathogenesis and clinical iplications
11. Mechanisms of tissue injury
12. Cytokines and inflammatory mediators
13. T-lymphocyte dysregulation
14. Neuroimmune interactions in the inflamed intestine
15. Fibrogenesis
16. Colorectal Cancer in Inflammatory bowel disease: molecular considerations
Section III: Epidemiology, Clinical features and natural history
17.The Epidemiology of Inflammatory Bowel Diseases
18. Clinical Genetics of Inflammatory Bowel Diseases
19. Clinical Course and natural history of Ulcerative colitis
20. Clinical features and natural history of Crohn's diseases
21. Clinical features and natural history of pediatric inflammatory bowel diseases
22. Physiologic consequences of surgical treatment for inflammatory bowel disease
23. Fertility and pregnancy
24. Phychosocial factors in ulcerative colitis and crohn's disease
Section IV. Diagnosis and Evaluation
25. Differential Diagnosis of inflammatory bowel disease
26. Endoscopy in Inflammatory Bowel Disease
27. Pathology of Idiopathic Inflammatory Bowel Disease
28. Imaging of the Idiopathic inflammatory bowel disease
29. Serology and laboratory markers of disease activities
Section V. Medical Therapy
30. Clinical trial design with an emphasis on indices to measure disease activity
31. Quality of life and phamacoeconomics
32. Pharmacology of inflammatory bowel disease therapy
33. Medical therapy for ulcerative colitis
34. Medical therapy for crohn's disease
35. Medical and nutritional therapy for pediatric inflammatory bowel disease
36. Nutrition in Inflammatory bowel disease
37. New therapeutic drugs for inflammatory bowel disease
Section VI. Surgical therapy
38. Indications for Surgery in inflammatory bowel disease from the gastroenterologist's point of view
39. Indications for surgery: a surgeon's opinion
40. Surgical management of ulcerative colitis
41. Surgery for Crohn's disease
42. Care of the patient with a fecal diversion
Section VII. Complications and associated diseases
43. Cancer in inflammatory bowel disease-clinical considerations
44. Primary sclerosing cholangitis
45. Extraintestinal manifestation: Skin, joint and mucocutaneous manifestations
46. Pouchitis
47. Postoperative recurrence of crohn's disease
48. Microscopic colitis
49. Fistulizing Crohn's disease
50. Osteoporosis
There are no comments on this title.